Skip to content
OpenCapital
Get started

Calidi Biotherapeutics CLDI Q4 2024 Annual earnings

Reported April 4, 2025 · Before market open

Revenue$1.5M
EPS-$0.51Miss by $0.14
EPS estimate-$0.37

Next report

Aug 18, 2026 (In 2 weeks)

Versus estimates

Revenue

Q4 2024$1.5M

Diluted EPS

Q1 2026-$0.43Q4 2025-$0.57Beat by $0.99Q3 2025-$2.21Miss by $0.53Q2 2025-$1.99Miss by $0.07Q1 2025-$2.16Miss by $2.01
Q4 2024-$0.51Miss by $0.14

Ask the moment Calidi Biotherapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Calidi Biotherapeutics report Q4 2024 earnings?
Calidi Biotherapeutics (CLDI) reported Q4 2024 earnings on April 4, 2025 before market open.
What were Calidi Biotherapeutics's Q4 2024 revenue and EPS?
Calidi Biotherapeutics reported revenue of $1.5M and eps of $-0.51 for Q4 2024.
Did Calidi Biotherapeutics beat estimates in Q4 2024?
EPS missed the consensus estimate of $-0.37 by $0.14.
Where can I find Calidi Biotherapeutics's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001641172-25-001810) directly on SEC EDGAR. The filing index links above go to sec.gov.